KI-Beratung Beta

  • Produktbild: The Politics of the International Pricing of Prescription Drugs
  • Produktbild: The Politics of the International Pricing of Prescription Drugs

The Politics of the International Pricing of Prescription Drugs

101,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Harrison analyzes how the U.S. research pharmaceutical industry, faced with domestic political opposition to the prices it charged for prescription drugs, chose to pursue its policy goal of greater appropriability of its intellectual property through the institutions of foreign economic policymaking....

Beschreibung

Harrison analyzes how the U.S. research pharmaceutical industry, faced with domestic political opposition to the prices it charged for prescription drugs, chose to pursue its policy goal of greater appropriability of its intellectual property through the institutions of foreign economic policymaking.
As Harrison explains, a new body of literature has developed to analyze the emergence of intellectual property as a major international trade issue. For many researchers, the inclusion of trade related intellectual property (TRIPS) into the Uruguay round of the General Agreement on Tariffs and trade (GATT) negotiations marks an important demonstration of the political influence of U.S. knowledge-intensive industries. However, as he demonstrates, a more thorough specification of the domestic political environment reveals that the research pharmaceutical industry was incapable of achieving its domestic policy objectives at the same time that it is credited with immense international political power.
By providing a theory of institutional choice, Harrison reconciles this incongruity. He explains the strategic choices of the research pharmaceutical industry as a function of the transaction costs associated with pursuing its policy objectives within a variety of institutional alternatives. He concludes that he internationalization of intellectual property rights was a result of the changing domestic political environment in which the research pharmaceutical industry found itself the loser in a series of domestic economic policy battles. A thoughtful analysis of particular important to scholars, researchers, and policy makers involved with international trade, intellectual property, the pharmaceutical industry, and public policy.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

30.03.2004

Verlag Bloomsbury Academic
Seitenzahl

224

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

30.03.2004

Verlag Bloomsbury Academic
Seitenzahl

224

Maße (L/B/H)

24/16,1/1,7 cm

Gewicht

455 g

Sprache

Englisch

ISBN

978-0-275-98010-8

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: The Politics of the International Pricing of Prescription Drugs
  • Produktbild: The Politics of the International Pricing of Prescription Drugs
  • List of Tables
    List of Figures
    Introduction
    Theory
    Intellectual Property and Public Goods
    Domestic Politics: A History of the U.S. Research Pharmaceutical Industry
    Domestic Politics: A Domestic Solution to an International Problem
    International Politics: Bilateralism without Institutionalization
    International Politics: Bilateralism with Institutionalization
    International Politics: The Move Towards Multilateralism
    Conclusion
    Selected Bibliography